Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 19 - Hybrid peptides
Patents for C07K 19 - Hybrid peptides (29,428)
11/2003
11/27/2003US20030219419 Alteration of cell membrane for new functions
11/27/2003US20030219413 Method for overexpression of zwitterionic polysaccharides
11/27/2003US20030219402 Drug delivery of a fusion protein comprising plurality of component molecules linked with a linker, containing an enzyme cleavage site to be cleaved by an enzyme in a treated subject
11/27/2003US20030219375 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
11/27/2003CA2486583A1 Marker molecules associated with lung tumors
11/27/2003CA2486529A1 Novel phospholipases and uses thereof
11/26/2003EP1365032A1 Marker molecules associated with lung tumors
11/26/2003EP1365028A1 Method for expression of PDGF or IGF proteins in yeast
11/26/2003EP1364212A2 Three hybrid assay system
11/26/2003EP1364032A1 Use of fusion proteins whose n-terminal part is a hirudin derivative for the production of recombinant proteins via secretion by yeasts
11/26/2003EP1364030A2 Supersecretable peptides, processes for their production, and parallel improvement of the secreted form of one or more other polypeptides
11/26/2003EP1364029A1 Fusion protein for the secretion of a protein of interest into the supernatant of the bacterial culture
11/26/2003EP1364023A2 Method of diagnosing and treating cartilage disorders
11/26/2003EP1363944A2 High-affinity antagonists of elr-cxc chemokines
11/26/2003EP1363943A2 Interferon regulatory factor-1/human estrogen receptor fusion protein and its use for treating carcinomas
11/26/2003EP1363942A2 Polypeptide from a hdm2 protein specific murine alpha/beta t-cell receptors, nucleic acids coding for the above and use thereof
11/26/2003EP1363941A2 Histidine phosphatase interacting protein of 120 kd
11/26/2003EP1363938A2 Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
11/26/2003EP1363935A2 Ter sites and ter binding proteins
11/26/2003EP1224471B1 Dpi-6, a therapeutic biomarker in neurological disorders
11/26/2003EP0871492B1 Mesothelium antigen and methods and kits for targeting it
11/26/2003EP0705278B1 Apoptose inhibitor
11/26/2003EP0635054B1 Mammalian melanocyte stimulating hormone receptors and uses
11/26/2003EP0590058B1 HUMANIZED Heregulin ANTIBODy
11/26/2003CN1458977A Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug
11/26/2003CN1458846A Synthetic erythropoiesis stimulating protein
11/25/2003US6652851 Cloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon
11/20/2003WO2003095971A2 Posh nucleic acids, polypeptides and related methods
11/20/2003WO2003095493A2 Toxin-related antibodies with antimicrobial and antiviral activity
11/20/2003WO2003095488A1 Chimeric antagonist anth1
11/20/2003WO2003070192A9 Compositions and methods for surrogate antibody modulation of an immune response and transport
11/20/2003WO2003035891A3 Method for formulating and immobilizing a protein matrix and a protein matrix for use in a sensor
11/20/2003WO2003020756A3 Hybrid and tandem expression of neisserial proteins
11/20/2003WO2003016506A3 Secreted proteins
11/20/2003WO2003008444A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
11/20/2003WO2003000021A3 Pancam nucleic acids and polypeptides
11/20/2003WO2002090530A3 Kinases and phosphatases
11/20/2003WO2002060935A3 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences
11/20/2003WO2002055547A3 Sfrp and peptide motifs that interact with sfrp and methods of their use
11/20/2003US20030217385 Comprises insect-toxic peptide/fusion proteins for use in generating disease resistant plants; biological pest control; disease resistant plants
11/20/2003US20030216563 Kinase Wee1 fusion protein compositions, nucleotide sequences, expression systems, and methods of use
11/20/2003US20030216546 Genetically engineered fusion proteins for use in diagnosis and treatment of cancer, viral infections, autoimmune and alloimmune diseases
11/20/2003US20030215903 Nanostructures containing PNA joining or functional elements
11/20/2003US20030215880 Motif-grafted hybrid polypeptides and uses thereof
11/20/2003US20030215874 Isolated GRP94 ligand binding domain polypeptide and nucleic acid encoding same, crystalline form of same, and screening methods employing same
11/20/2003US20030215852 Novel pancortin-Pablo protein interactions and methods of use thereof
11/20/2003US20030215822 Comprises nucleotide sequences coding polypeptide for use in diagnosis, treatment and prevention of cell proliferative, autoimmune/inflammatory, cardiovascular, neurological and developmental disorder
11/20/2003US20030215457 Comprising a nucleic acid, a polypeptide encoded by the nucleic acid, and a compound, preferably an antibody or fragment thereof, that binds to the polypeptide, preferably binding to the extracellular domain of LIV-1 polypeptide
11/20/2003US20030215402 Porphyromonas gingivalis recombinant proteins and truncations
11/20/2003CA2485439A1 Anth1 chimeric antagonist
11/20/2003CA2484704A1 Toxin-related antibodies with antimicrobial and antiviral activity
11/19/2003EP1362868A2 Humanized and chimeric monoclonal antibodies that bind epidermal growth factor receptor (EGF-R)
11/19/2003EP1362106A2 Streptococcus pyogenes polypeptides and corresponding dna fragments
11/19/2003EP1362105A2 Anti-interferon-alpha antibodies
11/19/2003EP1362062A1 Concatameric immunoadhesion
11/19/2003EP1361893A1 Modified anti-egfr antibodies with reduced immunogenicity
11/19/2003EP1361892A1 Binding domain-immunoglobulin fusion proteins
11/19/2003EP0934425B1 Renilla luciferase and green fluorescent protein fusion genes
11/19/2003CN1457257A Extended native chemical ligation
11/19/2003CN1128157C Conjugate of lidamycin with active fragment of monoclonal antibody
11/18/2003US6649370 Isolated polynucleotide which induces a immune response when administered to a mammal; expression vectors; vaccines
11/18/2003CA1341447C Mutant t-pa with kringle replacement
11/13/2003WO2003093422A2 Novel tissue factor targeted antibodies as anticoagulants
11/13/2003WO2003093321A1 Fusion polypeptide, use thereof and methods employing it
11/13/2003WO2003092737A1 Fusions of cytokines and tumor targeting proteins
11/13/2003WO2003092602A2 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
11/13/2003WO2003076621A3 Vpr modulators and uses thereof
11/13/2003WO2003064614A3 Transport peptides and uses therefor
11/13/2003WO2003061365A3 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
11/13/2003WO2003060143A3 Efficient protein expression system
11/13/2003WO2003040391A3 Method for producing and identifying soluble protein domains
11/13/2003WO2003033654A3 Direct targeting binding proteins
11/13/2003WO2003033653A3 Affinity enhancement agents
11/13/2003WO2002095058A9 Emission ratiometric indicators of phosphorylation
11/13/2003US20030213016 Cyclin D polynucleotides polypeptides and uses thereof
11/13/2003US20030213003 Preparing and recoverng genetically engineered fusion protein for treating diabetes
11/13/2003US20030211560 Bioluminescent protease assay
11/13/2003US20030211511 Nucleic acids and proteins with thioredoxin reductase activity
11/13/2003US20030211112 EGFR ligands and methods of use
11/13/2003CA2484425A1 Fusions of cytokines and tumor targeting proteins
11/13/2003CA2483909A1 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
11/12/2003EP1360314A2 Chemically defined medium for cultured mammalian cells
11/12/2003EP1360311A2 Membrane penetrating peptides and uses thereof
11/12/2003EP1360307A2 Chimeric polypeptides of serum albumin and uses related thereto
11/12/2003EP1360197A2 Histidine phosphatase interacting protein with 240kd
11/12/2003EP1359932A2 Tip39 polypeptides
11/12/2003EP0773952B1 Interaction trap systems for detecting protein interactions
11/12/2003EP0742829B1 Expression of heterologous proteins in attenuated bacteria using the htra-promoters
11/12/2003CN1127568C Fibroblast growth factor homologs
11/12/2003CN1127351C Method for inducing antigen-specific T cell tolerance
11/11/2003USRE38313 4 immunoglobulin type extracellular domains having arginine residues substituted by glutamic acid; immunosuppressants; preventing specific binding to major histocompatibility complex
11/11/2003US6645933 Polypeptide that binds extracellular domain of human Flt4 receptor tyrosine kinase; genetic engineering; endothelial cell growth factors and genes
11/11/2003US6645775 Insulin-like growth factor agonist molecules
11/11/2003US6645761 Use to enhance the expression of the encoded polypeptide in mammalian cells
11/11/2003US6645740 Nucleic acids encodings equine GM-CSF
11/11/2003US6645501 Anti-pathogen system and methods of use thereof
11/11/2003US6645484 Endothelial cell transmembrane tyrosine kinase ligand
11/11/2003CA2056279C Cell-free receptor binding assays, the production and use thereof
11/06/2003WO2003091443A1 Synthetic transfer complex and method for transferring nucleic acids
11/06/2003WO2003091442A1 Improved chimeric glycoproteins and pseudotyped lentiviral vectors
1 ... 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 ... 295